Selected Publications

1. Aziz Ahmad, Hesham Refaat, Sanghati Bhattacharya, Vadim J. Gurvich, Anurag S. Rathore, Reza Nejadnik, and Raj Suryanarayanan. Effect of formulation composition on trastuzumab stability. International Journal of Pharmaceutics, 2025.
2. Hesham Refaat, Aziz Ahmad, Eman Kamel, Vadim J. Gurvich, Anurag S. Rathore, Raj Suryanarayanan, and Reza Nejadnik. Challenges with effective removal of surfactants from monoclonal antibody formulations. International journal of pharmaceutics, 2025.
3. Yusra Rahman, Siddhanth Hejmady, Reza Nejadnik. Prediction of Self-Association and Solution Behavior of Monoclonal Antibodies Using the QCM-D Metric of Loosely Interacting Layer. Molecular Pharmaceutics, 2024.
4. Deepika Sarin, Kunal Krishna, M. Reza Nejadnik, Raj Suryanarayanan, and Anurag S. Rathore. Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability, Molecular Pharmaceutics 2024 21 (4), 1872-1883.
5. Fast J, Christian T, Crul M, Jiskoot W , Nejadnik MR, Medina A, Radwick, A, Sreedhara, A, & Tole, H. Use of Closed System Transfer Devices (CSTDs) with Protein-Based Therapeutic Drugs-A Non-Solution for a Non-Problem?. Journal of Pharmaceutical Sciences, 2024; 113(2), 298–305.
6. Sreedhara A, Buecheler J, Brosig S, Chou D, Christian T, Das T, de Jong I, Fast J, Jagannathan B, Medina Morales A, Moussa EM, Nejadnik MR, Prajapati I, Radwick A, Rahman Y & Singh S. End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics, The AAPS Journal 2023.
7. Nejadnik MR, Randolph TW, Volkin DB, Schöneich C, Carpenter JF, Crommelin DJA, Jiskoot W. Post-production handling and administration of protein pharmaceuticals and potential instability issues, Journal of Pharmaceutical Sciences 2018;107:2013-2019.
8. Vlieland ND, Nejadnik MR, Gardarsdottir H, Romeijn S, Sediq AS, Bouvy ML, Egberts ACG, van den Bemt BJF, Jiskoot W. The impact of inadequate temperature storage conditions on aggregate and particle formation in drugs containing tumor necrosis factor-alpha inhibitors, Pharmaceutical Research 2018;35:42.
9. El Bialy I, Jiskoot W, Nejadnik MR. Formulation, delivery and stability of bone morphogenetic proteins for effective bone regeneration, Pharmaceutical Research 2017;34:1152-1170.
10. Jiskoot W, Nejadnik MR, Sediq AS. Potential issues with the handling of biologicals in a hospital, Journal of Pharmaceutical Sciences 2017;106:1688-1689.
11. Sediq AS, Waasdorp SKD, Nejadnik MR, van Beers MMC, Meulenaar J, Verrijk R, Jiskoot W. Determination of the porosity of PLGA microparticles by tracking their sedimentation velocity using a flow imaging microscope (FlowCAM), Pharmaceutical Research 2017;34:1104-1114.
12. Tian X, Nejadnik MR, Baunsgaard D, Henriksen A, Rischel C, Jiskoot W. A Comprehensive Evaluation of Nanoparticle Tracking Analysis (NanoSight) for Characterization of Proteinaceous Submicron Particles, Journal of Pharmaceutical Sciences 2016;105:3366-3375.
13. Sediq AS, Van Duijvenvoorde R, Jiskoot W, Nejadnik MR. No touching! Abrasion of adsorbed protein is the root cause of subvisible particle formation during stirring, Journal of Pharmaceutical Sciences 2016;105:519-529.
14. Monkare J, Nejadnik MR, W Jiskoot, Bouwstra J. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery, Journal of Controlled Release 2015;218:53-62.
15. Nejadnik MR, Jiskoot W. Measurement of the average mass of proteins adsorbed to a nanoparticle by using a suspended microchannel resonator, Journal of Pharmaceutical Sciences 2015;104:698-704.